Literature DB >> 12642636

Postmenopausal hormones--therapy for symptoms only.

Deborah Grady1.   

Abstract

Mesh:

Year:  2003        PMID: 12642636     DOI: 10.1056/NEJMp030038

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

Review 1.  Cardiology.

Authors:  Tom Fahey; Knut Schroeder
Journal:  Br J Gen Pract       Date:  2004-09       Impact factor: 5.386

2.  [Evidence based basis of decision making for or against a postmenopausal hormone treatment].

Authors:  Eva Rásky
Journal:  Wien Klin Wochenschr       Date:  2004-07-31       Impact factor: 1.704

3.  Time to review all the evidence for hormone replacement therapy.

Authors:  Fay Crawford; Peter Langhorne
Journal:  BMJ       Date:  2005-02-12

Review 4.  Economic evaluations of interventions for the prevention and treatment of osteoporosis: a structured review of the literature.

Authors:  Rachael L Fleurence; Cynthia P Iglesias; David J Torgerson
Journal:  Osteoporos Int       Date:  2005-06-25       Impact factor: 4.507

5.  Performance of four clinical screening tools to select peri- and early postmenopausal women for dual X-ray absorptiometry.

Authors:  B Rud; J E B Jensen; L Mosekilde; S P Nielsen; J Hilden; B Abrahamsen
Journal:  Osteoporos Int       Date:  2004-09-30       Impact factor: 4.507

Review 6.  Current breast cancer risks of hormone replacement therapy in postmenopausal women.

Authors:  Nirav R Shah; Tanping Wong
Journal:  Expert Opin Pharmacother       Date:  2006-12       Impact factor: 3.889

Review 7.  Cardiovascular consequences of hormone therapy in postmenopausal women: Messages to clinicians.

Authors:  O Ylikorkala; T Mikkola
Journal:  Reprod Med Biol       Date:  2005-03-07

8.  Treatment with qibaomeiran, a kidney-invigorating Chinese herbal formula, antagonizes estrogen decline in ovariectomized rats.

Authors:  Ying Xu; Xiao-ping Ma; Jie Ding; Zhen-li Liu; Zhi-qian Song; Hong-ning Liu; Na Lin
Journal:  Rejuvenation Res       Date:  2014-08       Impact factor: 4.663

Review 9.  The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature.

Authors:  Rachael L Fleurence; Cynthia P Iglesias; Jeanene M Johnson
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 10.  [Current diagnosis and therapy of osteoporosis on the basis of "European guidance 2008"].

Authors:  R Bartl; R Gradinger
Journal:  Orthopade       Date:  2009-04       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.